Treatment by miglustat of a young adult presenting type 1 Gaucher's disease

被引：0
|
作者：
Djerad, Hama [1 ]
机构：
[1] Ctr Hosp Nevers, Serv Med Interne, F-58000 Nevers, France
来源：
PRESSE MEDICALE | 2006年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S33 / S34
页数：2
相关论文
共 50 条
  • [21] Coxarthritis as the Presenting Symptom of Gaucher Disease Type 1
    Brisca, Giacomo
    Di Rocco, Maja
    Picco, Paolo
    BeatriceDamasio, Maria
    Martini, Alberto
    ARTHRITIS, 2011,
  • [22] Gaucher disease linked to a deficit in saposine C with treatment by miglustat
    Amsallem, Daniel
    PRESSE MEDICALE, 2006, 35 : S35 - S36
  • [23] A TREATMENT EXPERIENCE OF TYPE 3 GAUCHER DISEASE: PIRACETAM AND MIGLUSTAT THERAPY IN PROGRESSIVE MYOCLONIC EPILEPSY
    Onal, H.
    Adal, E.
    Ersen, A.
    Aydin, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S151 - S151
  • [24] Two-year oral miglustat in Gaucher disease type III
    Schiffmann, Raphael
    Chris, Harris
    Catherine, DeVile
    Elin, Davis-Pope
    Ed, Fitzgibbon
    Roscoe, Brady
    Larry, Abel
    Pauline, Campbell
    Ashok, Vellodi
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S33 - S33
  • [25] Treat type I Gaucher disease with miglustat - Experience with two patients
    Yang, Sandra
    Tifft, Cynthia
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S22 - S22
  • [26] Miglustat Therapy in Type 1 Gaucher Disease: Long-Term Treatment Experience From a Multicenter, Retrospective Cohort Study
    Kuter, David J.
    Mehta, Atul
    Hollak, Carla
    Giraldo, Pilar
    Hughes, Derralynn
    Belmatoug, Nadia
    Brand, Monika
    Muller, Audrey
    Schaaf, Berthold
    Giorgino, Ruben
    Zimran, Ari
    BLOOD, 2011, 118 (21) : 1385 - 1385
  • [27] Quality of life and psychological functioning of pediatric and young adult patients with Gaucher disease, type 1
    Alioto, Andrea G.
    Gomez, Rowena
    Moses, James
    Paternostro, Jennifer
    Packman, Seymour
    Packman, Wendy
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2020, 182 (05) : 1130 - 1142
  • [28] MIGLUSTAT THERAPY IN TYPE 1 GAUCHER DISEASE: LONG-TERM TREATMENT EXPERIENCE FROM A MULTICENTER, RETROSPECTIVE COHORT STUDY
    Hollak, C. E. M.
    Kuter, D.
    Giraldo, P.
    Hughes, D.
    Belmatoug, N.
    Brand, M.
    Muller, A.
    Schaaf, B.
    Giorgino, R.
    Zimran, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S97 - S97
  • [29] Patients with Gaucher type 1: Switching from imiglucerase to miglustat therapy
    Canda, Ebru
    Kose, Melis
    Kagnici, Mehtap
    Ucar, Sema Kalkan
    Sozmen, Eser Y.
    Coker, Mahmut
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 180 - 184
  • [30] Miglustat therapy in type 1 Gaucher disease: Clinical and safety outcomes in a multicenter retrospective cohort study
    Kuter, David J.
    Mehta, Atul
    Hollak, Carla E. M.
    Giraldo, Pilar
    Hughes, Derralynn
    Belmatoug, Nadia
    Brand, Monika
    Muller, Audrey
    Schaaf, Berthold
    Giorgino, Ruben
    Zimran, Ari
    BLOOD CELLS MOLECULES AND DISEASES, 2013, 51 (02) : 116 - 124
12345